Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Polycythemia Vera × Clopidogrel × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Thrombosis 1 Polycythemia Vera 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, Follicular 1 Ischemic Stroke 1 Head and Neck Neoplasms 1 Breast Neoplasms 1 Adenocarcinoma 1

Interventions

fludarabine phosphate 22 Cyclophosphamide 19 Peripheral Blood Stem Cell Transplantation 17 Busulfan 15 Whole-Body Irradiation 14 Mycophenolic Acid 12 ruxolitinib 11 Tacrolimus 11 Methotrexate 9 Cyclosporine 9 Antilymphocyte Serum 9 fludarabine 8 Melphalan 7 peginterferon alfa-2a 5 Aspirin 5 Stem Cell Transplantation 4 Radiotherapy 4 Filgrastim 4 Etoposide 4 Decitabine 4 Biopsy 4 Surveys and Questionnaires 3 Methylprednisolone 3 Injections 3 Imatinib Mesylate 3 Hydroxyurea 3 Flow Cytometry 3 Cytarabine 3 Blood Specimen Collection 3 Azacitidine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00940784 2014-11-26

ISCLAP

Icahn School of Medicine at Mount Sinai

Phase 2 Withdrawn

Polycythemia Vera

Data powered by HemOnc (CC BY 4.0) Colophon ⚡